Related Experiment Video
Updated: Apr 7, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Canine dysautonomia in a litter of Havanese puppies
Noah C Hull1, Donal O'Toole1, Myrna M Miller1
1Department of Veterinary Sciences, University of Wyoming, Laramie, WY (Hull, O'Toole, Miller, Shoults, Schumaker)Wyoming State Veterinary Laboratory, Laramie, WY (O'Toole, Miller, Schumaker)DVM, Gainesville, MO (Deck)Strothertowne Pet Hospital, Lee's Summit, MO (Jones)Department of Veterinary Medicine, University of Missouri, Columbia, MO (Johnson, Shaw).
Abstract:
Canine dysautonomia is a sporadic, generally fatal disease that rarely affects groups of related animals. Four 10-week-old Havanese puppies from a litter of 5 developed clinical signs of canine dysautonomia. The 4 affected dogs were exposed to an outdoor environment, whereas the fifth littermate was not exposed to the outdoors and remained clinically healthy. Clinical signs of dysautonomia developed 10-16 days after going outside the house. An unrelated dog also developed dysautonomia after exposure to 1 of the affected Havanese littermates. All 5 dogs had morphological changes consistent with dysautonomia (widespread neuronal degeneration in autonomic ganglia, select brainstem nuclei, and ventral horn motor neurons). Differential diagnoses were excluded through negative toxicological evaluation, fecal parasite screening, negative Canine distemper virus reverse transcription polymerase chain reaction, fluorescent antibody testing, attempted virus isolation, and electron microscopy. The 5 affected dogs were in the Kansas City, Missouri area, where there is a high incidence of dysautonomia.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure Drugs: Inotropic Agents
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure III: Clinical Manifestations
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure I: Introduction

